Is There Now An Opportunity In Uzin Utz AG (ETR:UZU)?

While Uzin Utz AG (ETR:UZU) might not be the most widely known stock at the moment, it saw significant share price movement during recent months on the XTRA, rising to highs of €61.40 and falling to the lows of €44.90. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Uzin Utz's current trading price of €44.90 reflective of the actual value of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at Uzin Utz’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.

Check out our latest analysis for Uzin Utz

Advertisement

What Is Uzin Utz Worth?

According to my price multiple model, which makes a comparison between the company's price-to-earnings ratio and the industry average, the stock price seems to be justfied. In this instance, I’ve used the price-to-earnings (PE) ratio given that there is not enough information to reliably forecast the stock’s cash flows. I find that Uzin Utz’s ratio of 8.59x is trading slightly below its industry peers’ ratio of 8.81x, which means if you buy Uzin Utz today, you’d be paying a decent price for it. And if you believe that Uzin Utz should be trading at this level in the long run, then there’s not much of an upside to gain over and above other industry peers. Furthermore, Uzin Utz’s share price also seems relatively stable compared to the rest of the market, as indicated by its low beta. This may mean it is less likely for the stock to fall lower from natural market volatility, which suggests less opportunities to buy moving forward.

Can we expect growth from Uzin Utz?

earnings-and-revenue-growth
XTRA:UZU Earnings and Revenue Growth September 20th 2022

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. With revenues expected to grow by a double-digit 17% over the next couple of years, the outlook is positive for Uzin Utz. If the level of expenses is able to be maintained, it looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.

What This Means For You

Are you a shareholder? UZU’s optimistic future growth appears to have been factored into the current share price, with shares trading around industry price multiples. However, there are also other important factors which we haven’t considered today, such as the financial strength of the company. Have these factors changed since the last time you looked at UZU? Will you have enough conviction to buy should the price fluctuate below the industry PE ratio?

Are you a potential investor? If you’ve been keeping an eye on UZU, now may not be the most advantageous time to buy, given it is trading around industry price multiples. However, the positive outlook is encouraging for UZU, which means it’s worth diving deeper into other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.

If you'd like to know more about Uzin Utz as a business, it's important to be aware of any risks it's facing. For instance, we've identified 3 warning signs for Uzin Utz (1 is a bit concerning) you should be familiar with.

If you are no longer interested in Uzin Utz, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About XTRA:UZU

Uzin Utz

Develops, manufactures, and sells construction chemical product systems in Germany, the United States, Netherlands, and internationally.

Flawless balance sheet, undervalued and pays a dividend.

Similar Companies

Advertisement

Weekly Picks

LO
Lou_Basenese
CUE logo
Lou_Basenese on Cue Biopharma ·

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

Fair Value:US$7065.0% undervalued
41 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
HA
HarishPK
ADBE logo
HarishPK on Adobe ·

Adobe: A Probabilistic Case for Undervaluation

Fair Value:US$319.9636.2% undervalued
45 users have followed this narrative
8 users have commented on this narrative
14 users have liked this narrative
NI
niteco
AVGO logo
niteco on Broadcom ·

A Capital Allocation Favorite with Structural Importance

Fair Value:US$651.0541.3% undervalued
43 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
TO
Tokyo
OKTA logo
Tokyo on Okta ·

Good foundation, but now it's all about the next steps

Fair Value:US$15123.0% undervalued
90 users have followed this narrative
7 users have commented on this narrative
11 users have liked this narrative

Updated Narratives

DC
DOCS logo
Dc12 on Doximity ·

High physician usership and impressive AI tools

Fair Value:US$33.740.5% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
RO
Rog
CTT logo
Rog on CTT - Correios De Portugal ·

Why CTT benefits in multiple ways right now

Fair Value:€6.6710.2% undervalued
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
ES
HSY logo
Esteban on Hershey ·

Hershey - fortress brand-and-scale position in U.S. confectionery: protects the downside far better than it compounds the upside

Fair Value:US$85.86111.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7446.4% undervalued
65 users have followed this narrative
0 users have commented on this narrative
15 users have liked this narrative
CL
Clive_Thompson
TTWO logo
Clive_Thompson on Take-Two Interactive Software ·

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

Fair Value:US$276.9723.5% undervalued
58 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative
NI
niteco
HON logo
niteco on Honeywell International ·

Honeywell - The Demand-Side of the AI Infrastructure

Fair Value:US$320.1931.2% undervalued
49 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative